Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds.

Hägerling R, Hoppe E, Dierkes C, Stehling M, Makinen T, Butz S, Vestweber D, Kiefer F.

EMBO J. 2018 Nov 15;37(22). pii: e98271. doi: 10.15252/embj.201798271. Epub 2018 Oct 8.

PMID:
30297530
2.

VIPAR, a quantitative approach to 3D histopathology applied to lymphatic malformations.

Hägerling R, Drees D, Scherzinger A, Dierkes C, Martin-Almedina S, Butz S, Gordon K, Schäfers M, Hinrichs K, Ostergaard P, Vestweber D, Goerge T, Mansour S, Jiang X, Mortimer PS, Kiefer F.

JCI Insight. 2017 Aug 17;2(16). pii: 93424. doi: 10.1172/jci.insight.93424. eCollection 2017 Aug 17.

3.

The role of fatty acid β-oxidation in lymphangiogenesis.

Wong BW, Wang X, Zecchin A, Thienpont B, Cornelissen I, Kalucka J, García-Caballero M, Missiaen R, Huang H, Brüning U, Blacher S, Vinckier S, Goveia J, Knobloch M, Zhao H, Dierkes C, Shi C, Hägerling R, Moral-Dardé V, Wyns S, Lippens M, Jessberger S, Fendt SM, Luttun A, Noel A, Kiefer F, Ghesquière B, Moons L, Schoonjans L, Dewerchin M, Eelen G, Lambrechts D, Carmeliet P.

Nature. 2017 Feb 2;542(7639):49-54. doi: 10.1038/nature21028. Epub 2016 Dec 26.

PMID:
28024299
4.

Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.

Lowe KL, Finney BA, Deppermann C, Hägerling R, Gazit SL, Frampton J, Buckley C, Camerer E, Nieswandt B, Kiefer F, Watson SP.

Blood. 2015 Jun 11;125(24):3769-77. doi: 10.1182/blood-2014-09-603803. Epub 2015 Apr 23.

5.

A transgenic Prox1-Cre-tdTomato reporter mouse for lymphatic vessel research.

Bianchi R, Teijeira A, Proulx ST, Christiansen AJ, Seidel CD, Rülicke T, Mäkinen T, Hägerling R, Halin C, Detmar M.

PLoS One. 2015 Apr 7;10(4):e0122976. doi: 10.1371/journal.pone.0122976. eCollection 2015.

6.

Fusing VE-cadherin to α-catenin impairs fetal liver hematopoiesis and lymph but not blood vessel formation.

Dartsch N, Schulte D, Hägerling R, Kiefer F, Vestweber D.

Mol Cell Biol. 2014 May;34(9):1634-48. doi: 10.1128/MCB.01526-13. Epub 2014 Feb 24.

7.

Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.

D'Amico G, Korhonen EA, Anisimov A, Zarkada G, Holopainen T, Hägerling R, Kiefer F, Eklund L, Sormunen R, Elamaa H, Brekken RA, Adams RH, Koh GY, Saharinen P, Alitalo K.

J Clin Invest. 2014 Feb;124(2):824-34. doi: 10.1172/JCI68897. Epub 2014 Jan 16.

8.

Visualization of lymphatic vessel development, growth, and function.

Pollmann C, Hägerling R, Kiefer F.

Adv Anat Embryol Cell Biol. 2014;214:167-86. doi: 10.1007/978-3-7091-1646-3_13. Review.

PMID:
24276894
9.

A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy.

Hägerling R, Pollmann C, Andreas M, Schmidt C, Nurmi H, Adams RH, Alitalo K, Andresen V, Schulte-Merker S, Kiefer F.

EMBO J. 2013 Mar 6;32(5):629-44. doi: 10.1038/emboj.2012.340. Epub 2013 Jan 8.

10.

Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation.

Sabine A, Agalarov Y, Maby-El Hajjami H, Jaquet M, Hägerling R, Pollmann C, Bebber D, Pfenniger A, Miura N, Dormond O, Calmes JM, Adams RH, Mäkinen T, Kiefer F, Kwak BR, Petrova TV.

Dev Cell. 2012 Feb 14;22(2):430-45. doi: 10.1016/j.devcel.2011.12.020. Epub 2012 Feb 2.

11.

Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse.

Hägerling R, Pollmann C, Kremer L, Andresen V, Kiefer F.

Biochem Soc Trans. 2011 Dec;39(6):1674-81. doi: 10.1042/BST20110722. Review.

PMID:
22103506

Supplemental Content

Loading ...
Support Center